Has Avrim Fishkind, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,427 in general payments to Avrim Fishkind, MD across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Avrim Fishkind, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Avrim Fishkind, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Avrim Fishkind, MD

Psychiatry · Houston, TXNPI 1093727943

Payments from drug & device makers

$7,427in general payments, 2019–2025

Across 27 payments — averaging $275.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$7K
Teva Pharmaceuticals USA, Inc.$318
Axsome Therapeutics, Inc.$99
Neurocrine Biosciences, Inc.$39
Indivior Inc.$35
Johnson & Johnson$30
plus $44 from 2 others

What the payments were for

Food & beverage$677100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	8	$6,861
Teva Pharmaceuticals USA, Inc.	8	$318
Axsome Therapeutics, Inc.	2	$99
Neurocrine Biosciences, Inc.	2	$39
Indivior Inc.	2	$35
Johnson & Johnson	2	$30
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$29
Luye Pharma (USA) Ltd.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Austedo XR$113
AUSTEDO$112

How this compares

$7,427 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas →

Medicare billing

Part B allowed, 2024

$44,912

Medicare patients

Services billed

347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	14	$24,444
Lurasidone Hcl	19	$6,751
Bupropion XlBupropion Hcl	59	$2,721
Aripiprazole	30	$2,381
Paliperidone ErPaliperidone	17	$2,059
Divalproex Sodium ErDivalproex Sodium	11	$1,301
Ziprasidone Hcl	18	$1,086
Temazepam	12	$1,032
Quetiapine Fumarate	74	$1,027
Gabapentin	53	$955
Hydroxyzine Hcl	38	$917
Venlafaxine Hcl ErVenlafaxine Hcl	52	$877
Benztropine Mesylate	66	$824
Olanzapine	35	$823
Clozapine	34	$703

Paid to pharmacies, not to this prescriber.

Other psychiatry in Houston

Matthew BramsHouston$3M
Lawrence GinsbergHouston$2.4M
Asim ShahHouston$2.2M
Aqeel HashmiHouston$1.3M
Robert EarleHouston$1.1M
Frank ChenHouston$941K
Joao de QuevedoHouston$890K
Alice MaoHouston$850K
Mazhar KhowajaHouston$843K
Barry GritzHouston$792K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →